These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2782166)

  • 1. The effect of calcium entry blocker S-emopamil on cerebrocortical metabolism and blood flow changes evoked by graded hypotension.
    Kovách AG; Nguyen LT; Pék L; Dezsi L; Lohinai ZS
    Adv Exp Med Biol; 1989; 248():461-70. PubMed ID: 2782166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of emopamil on cerebrocortical microcirculation during hypoxia and reactive hyperemia and on [K+]e, pH, pO2 changes during and after N2 anoxia.
    Urbanics R; Kovach AG
    Adv Exp Med Biol; 1989; 248():479-87. PubMed ID: 2782168
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of nimodipine and verapamil on cerebral blood flow and cerebrovascular reactivity in conscious rabbits.
    Weinstein GB
    Ann N Y Acad Sci; 1995 Sep; 765():334-5. PubMed ID: 7486637
    [No Abstract]   [Full Text] [Related]  

  • 4. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 2nd communication: brain penetration, cerebral vascular and metabolic effects.
    Szabo L
    Arzneimittelforschung; 1989 Mar; 39(3):309-14. PubMed ID: 2757656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 3rd communication: effect on postischemic cerebral blood flow and metabolism, and ischemic neuronal cell death.
    Szabo L; Hofmann HP
    Arzneimittelforschung; 1989 Mar; 39(3):314-9. PubMed ID: 2757657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of adenosine to the regulation of cerebral blood flow: the role of calcium ions in the adenosine-induced cerebrocortical vasodilatation.
    Kovách AG; Dóra E
    Adv Exp Med Biol; 1984; 169():315-25. PubMed ID: 6731093
    [No Abstract]   [Full Text] [Related]  

  • 7. (S)-emopamil attenuates acute reduction in regional cerebral blood flow following experimental brain injury.
    Okiyama K; Rosenkrantz TS; Smith DH; Gennarelli TA; McIntosh TK
    J Neurotrauma; 1994 Feb; 11(1):83-95. PubMed ID: 8201628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the organic calcium antagonist D-600 on cerebrocortical vascular and redox responses evoked by adenosine, anoxia, and epilepsy.
    Kovách AG; Dóra E; Szedlacsek S; Koller A
    J Cereb Blood Flow Metab; 1983 Mar; 3(1):51-61. PubMed ID: 6822618
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of a novel calcium channel blocker, (S)-emopamil, on regional cerebral edema and neurobehavioral function after experimental brain injury.
    Okiyama K; Smith DH; Thomas MJ; McIntosh TK
    J Neurosurg; 1992 Oct; 77(4):607-15. PubMed ID: 1527621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of emopamil on postischemic blood flow and neuronal damage in rat brain.
    Bielenberg GW; Sauer D; Nuglisch J; Beck T; Rossberg C; Mennel HD; Krieglstein J
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):230-5. PubMed ID: 2725698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile.
    Hofmann HP; Raschack M; Unger L
    Arzneimittelforschung; 1989 Mar; 39(3):304-8. PubMed ID: 2757655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (S)-emopamil protects against global ischemic brain injury in rats.
    Lin BW; Dietrich WD; Busto R; Ginsberg MD
    Stroke; 1990 Dec; 21(12):1734-9. PubMed ID: 2264081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cerebroprotective agents on cerebral blood flow and on postischemic energy metabolism in the rat brain.
    Bielenberg GW; Beck T; Sauer D; Burniol M; Krieglstein J
    J Cereb Blood Flow Metab; 1987 Aug; 7(4):480-8. PubMed ID: 3611206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of verapamil and diltiazem on the rCBF and the rCBF autoregulation in cortex and thalamus of cats.
    Gatchev E; Vlahov V
    Acta Physiol Pharmacol Bulg; 1995; 21(3):77-80. PubMed ID: 8868370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of neuronal calcium entry and [3H]-D-aspartate release by the quaternary derivatives of verapamil and emopamil.
    Keith RA; Mangano TJ; DeFeo PA; Ernst GE; Warawa EJ
    Br J Pharmacol; 1994 Oct; 113(2):379-84. PubMed ID: 7834187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acute arterial hypo- and hypertension on cerebrocortical NAD/NADH redox state and vascular volume.
    Dóra E; Kovách AG
    J Cereb Blood Flow Metab; 1982; 2(2):209-19. PubMed ID: 7076733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
    Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
    Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of NMDA and calcium channel antagonists on regional cerebral blood flow.
    Lo EH; Sun GH; Steinberg GK
    Neurosci Lett; 1991 Sep; 131(1):17-20. PubMed ID: 1791974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of phenylalkylamine calcium entry blockers on postischemic energy metabolism in the isolated perfused rat brain: stereoselective action of emopamil.
    Weber J; Bielenberg GW; Krieglstein J
    Pharmacology; 1988; 37(1):38-49. PubMed ID: 2458606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of dilceren (nimodipine) on the cerebral circulation in the intact animals and animals subjected to ischemic brain damage].
    Aleksandrin VV; Khaĭlov NA; Mirzoian GR; Gan'shina TS
    Eksp Klin Farmakol; 2002; 65(2):17-9. PubMed ID: 12109284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.